amiodarone has been researched along with Acute Disease in 96 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone has been implicated as a risk factor for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) when used in the hospital." | 9.16 | Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk. ( Carter, RE; Festic, E; Gajic, O; Karnatovskaia, LV; Lee, AS, 2012) |
| "This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF)." | 9.15 | A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. ( Beatch, G; Camm, AJ; Capucci, A; Hohnloser, SH; Mangal, B; Torp-Pedersen, C; Van Gelder, IC, 2011) |
| "The aim of our study was to compare the efficacy and safety of ibutilide and amiodarone (intravenously) in converting recent-onset atrial fibrillation (AF) and atrial flutter (Af) to sinus rhythm (SR)." | 9.12 | Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. ( Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP, 2007) |
| "Intravenous dofetilide is significantly more effective than amiodarone or placebo in restoring sinus rhythm in patients with atrial fibrillation or flutter." | 9.09 | Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. ( Alboni, P; Bianconi, L; Castro, A; Dinelli, M; Pappalardo, A; Richiardi, E; Santini, M, 2000) |
| "A randomized, single-blind controlled study intended to assess the potential benefits of intravenous amiodarone in anterior myocardial infarction is presented." | 9.06 | Intravenous amiodarone in acute anterior myocardial infarction: a controlled study. ( Boccia, AS; D'Alterio, D; Greco, R; Mininni, N; Musto, B; Schiattarella, M; Wolff, S, 1989) |
| "Amiodarone-associated thyrotoxicosis may be severe and refractory to medical therapy." | 8.80 | Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. ( Burgess, JR; Claxton, S; Donovan, S; Greenaway, TM; Hoffman, L; Loughhead, M; Sinha, SN, 2000) |
| "One of the drugs that are widely used in the treatment of atrial fibrillation is amiodarone." | 7.91 | TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY. ( Cerovec, D; Ciglenečki, N; Lakušić, N; Slivnjak, V, 2019) |
| "A 54-year-old man with the lysosomal storage disorder Anderson-Fabry disease (AFD) and cardiac involvement was placed on amiodarone for treatment of symptomatic paroxysmal atrial fibrillation." | 7.91 | Acute Decompensated Heart Failure After Initiation of Amiodarone in a Patient With Anderson-Fabry Disease. ( Fine, NM; Khan, A; Wang, Y, 2019) |
| "There is still lack of strong evidence, based on systematic studies, that support the relationship between amiodarone use and the risk of acute pancreatitis." | 7.81 | Amiodarone use and risk of acute pancreatitis: A population-based case-control study. ( Lai, SW; Liao, KF; Lin, CL; Lin, CY, 2015) |
| "Amiodarone has been implicated as a cause of thrombocytopenia but the responsible mechanism is unknown." | 7.79 | Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins. ( Aster, R; Bougie, D; Caulfield, M; Clarke, N; Koch, R; Sahud, MA, 2013) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 7.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Amiodarone, a class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia." | 7.74 | Acute pancreatitis and amiodarone: a case report. ( Chen, CY; Chen, YY; Leung, KK, 2007) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 7.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| "A retrospective review was done to determine the efficacy and hemodynamic effects of slow intravenous amiodarone administration on invasively monitored patients with acute onset of atrial fibrillation or atrial flutter and left ventricular ejection fractions < 15%." | 7.69 | Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. ( Kumar, A, 1996) |
| "Amiodarone seems, in this study, to be a very effective antiarrhythmic drug for the treatment of supraventricular tachyarrhythmias." | 7.68 | [The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia]. ( de Castro, JJ; Mota, E; Quadrado, C; Soares, Ade O, 1990) |
| "Few data are available on intravenous amiodarone therapy in refractory arrhythmias." | 7.67 | Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. ( Binner, L; König, W; Mayer, U; Schmidt, A; Stauch, M, 1988) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 7.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "Diffuse alveolar hemorrhage is a rare reaction, with few case reports documented in the literature since amiodarone became widely used in the early 1980s." | 5.38 | A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: a case report. ( Bennett, S; Borders, CW; Claassen, SL; Mount, C, 2012) |
| " Its long-term use may, however, lead to several adverse effects, with pulmonary toxicity being the most serious." | 5.37 | Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema. ( Bolognese, L; Brandini, R; Caremani, M; Fabiani, I; Grotti, S; Salvadori, C; Tacconi, D, 2011) |
| "Congestive heart failure was diagnosed in 6 patients (ejection fraction < 25%) and hypertensive heart failure in 3 patients (ejection infarction > 55%)." | 5.31 | [Control of tachycardia with intravenous amiodarone in acute left heart failure]. ( Arabadzisz, H; Beck, K; Marosi, A; Tomcsányi, J; Zsoldos, A, 2001) |
| "Amiodarone is a new and powerful antiarrhythmic agent currently under investigation in North America." | 5.27 | Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease. ( Pollak, PT; Sami, M, 1984) |
| "Amiodarone has been implicated as a risk factor for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) when used in the hospital." | 5.16 | Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk. ( Carter, RE; Festic, E; Gajic, O; Karnatovskaia, LV; Lee, AS, 2012) |
| "This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF)." | 5.15 | A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. ( Beatch, G; Camm, AJ; Capucci, A; Hohnloser, SH; Mangal, B; Torp-Pedersen, C; Van Gelder, IC, 2011) |
| "Patients received intravenous flecainide, propafenone, or amiodarone on presentation and a second dose after 6 hours if atrial fibrillation persisted." | 5.14 | Management of patients with acute atrial fibrillation in the ED. ( Abbate, R; Conti, A; Del Taglia, B; Gensini, GF; Grifoni, S; Mariannini, Y; Michelucci, A; Padeletti, L; Pepe, G; Vanni, S, 2010) |
| "We conducted a prospective clinical trial of 111 consecutive patients admitted to our ICU after cardiac surgery (basically, coronary artery bypass graft and/or valve surgery) and who received short-term prophylactic amiodarone treatment if they were considered at high risk of developing atrial fibrillation." | 5.12 | Is short-term amiodarone use post cardiac surgery a cause of acute respiratory failure? ( Carrió, ML; Castells, E; Farrero, E; Fortià, C; Javierre, C; Ricart, A; Rodríguez, D; Ventura, JL, 2007) |
| "The aim of our study was to compare the efficacy and safety of ibutilide and amiodarone (intravenously) in converting recent-onset atrial fibrillation (AF) and atrial flutter (Af) to sinus rhythm (SR)." | 5.12 | Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. ( Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP, 2007) |
| "Intravenous dofetilide is significantly more effective than amiodarone or placebo in restoring sinus rhythm in patients with atrial fibrillation or flutter." | 5.09 | Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. ( Alboni, P; Bianconi, L; Castro, A; Dinelli, M; Pappalardo, A; Richiardi, E; Santini, M, 2000) |
| "To evaluate differences between amiodarone, procainamide and quinidine in the time delay necessary to convert acute atrial fibrillation (AF) to sinus rhythm." | 5.07 | [Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?]. ( Amato, RV; Bellotti, G; César, LA; D'Avila, AL; Ferreira, JF; Pamplona, D; Pfeferman, E; Scanavacca, M; Serrano, CV; Sosa, EA, 1994) |
| "A randomized, single-blind controlled study intended to assess the potential benefits of intravenous amiodarone in anterior myocardial infarction is presented." | 5.06 | Intravenous amiodarone in acute anterior myocardial infarction: a controlled study. ( Boccia, AS; D'Alterio, D; Greco, R; Mininni, N; Musto, B; Schiattarella, M; Wolff, S, 1989) |
| "Amiodarone-associated thyrotoxicosis may be severe and refractory to medical therapy." | 4.80 | Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. ( Burgess, JR; Claxton, S; Donovan, S; Greenaway, TM; Hoffman, L; Loughhead, M; Sinha, SN, 2000) |
| "One of the drugs that are widely used in the treatment of atrial fibrillation is amiodarone." | 3.91 | TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY. ( Cerovec, D; Ciglenečki, N; Lakušić, N; Slivnjak, V, 2019) |
| "A 54-year-old man with the lysosomal storage disorder Anderson-Fabry disease (AFD) and cardiac involvement was placed on amiodarone for treatment of symptomatic paroxysmal atrial fibrillation." | 3.91 | Acute Decompensated Heart Failure After Initiation of Amiodarone in a Patient With Anderson-Fabry Disease. ( Fine, NM; Khan, A; Wang, Y, 2019) |
| "There is still lack of strong evidence, based on systematic studies, that support the relationship between amiodarone use and the risk of acute pancreatitis." | 3.81 | Amiodarone use and risk of acute pancreatitis: A population-based case-control study. ( Lai, SW; Liao, KF; Lin, CL; Lin, CY, 2015) |
| "Amiodarone has been implicated as a cause of thrombocytopenia but the responsible mechanism is unknown." | 3.79 | Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins. ( Aster, R; Bougie, D; Caulfield, M; Clarke, N; Koch, R; Sahud, MA, 2013) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 3.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Amiodarone, a class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia." | 3.74 | Acute pancreatitis and amiodarone: a case report. ( Chen, CY; Chen, YY; Leung, KK, 2007) |
| " Suddenly on the 6th day of the so far uncomplicated AMI ventricular fibrillation developed and was successfully treated with DC shock, and amiodarone (150 mg i." | 3.73 | [Polymorphic ventricular tachycardia in acute myocardial infarction without ST elevation in a patient with thrombocytopenia]. ( Bromblik, A; Bryniarski, L; Czamara, M; Dragan, J; Kukla, P; Szczuka, K; Słowiak-Lewińska, T, 2006) |
| " Intratracheal AM administration resulted in pulmonary fibrosis 21 days posttreatment, as evidenced by an increased hydroxyproline content and histological damage." | 3.72 | Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. ( Brien, JF; Card, JW; Margolin, SB; Massey, TE; Racz, WJ, 2003) |
| "A retrospective review was done to determine the efficacy and hemodynamic effects of slow intravenous amiodarone administration on invasively monitored patients with acute onset of atrial fibrillation or atrial flutter and left ventricular ejection fractions < 15%." | 3.69 | Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. ( Kumar, A, 1996) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 3.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| "Intravenous amiodarone is an effective treatment for supraventricular and ventricular tachyarrhythmias." | 3.69 | Acute pulmonary toxicity in an infant from intravenous amiodarone. ( Daniels, CJ; Franklin, WH; Hammond, S; Schutte, DA, 1997) |
| "Amiodarone seems, in this study, to be a very effective antiarrhythmic drug for the treatment of supraventricular tachyarrhythmias." | 3.68 | [The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia]. ( de Castro, JJ; Mota, E; Quadrado, C; Soares, Ade O, 1990) |
| "Few data are available on intravenous amiodarone therapy in refractory arrhythmias." | 3.67 | Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. ( Binner, L; König, W; Mayer, U; Schmidt, A; Stauch, M, 1988) |
| "Ninety-six patients with life-threatening ventricular arrhythmias refractory to two or more conventional agents were treated with amiodarone and followed for 6 to 40 months (mean, 15 months)." | 3.66 | Amiodarone in refractory life-threatening ventricular arrhythmias. ( Cannom, DS; Feld, G; Hendrickson, J; Intarachot, V; Lopez, B; Nademanee, K; Singh, BN; Weiss, JL, 1983) |
| "We present a 61-year-old patient with persistent atrial fibrillation who, after a one-month treatment with oral amiodarone at a low dose impregnation of 400 mg/day, develops acute pulmonary toxicity, with radiographic and tomographic resolution after antiarrhythmic suspension and steroid treatment." | 1.56 | [Acute amiodarone pulmonary toxicity with low impregnation dose: case report]. ( Cabrera-Rego, JO; Luzurriaga Navas, JD; Yanes Quintana, AA, 2020) |
| " But, selenium may have toxic effects in high doses." | 1.56 | Use of an antiarrhythmic drug against acute selenium toxicity. ( Başbuğan, Y; Keleş, ÖF; Kömüroğlu, AU; Mercan Yücel, U; Uyar, A, 2020) |
| "Diffuse alveolar hemorrhage is a rare reaction, with few case reports documented in the literature since amiodarone became widely used in the early 1980s." | 1.38 | A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: a case report. ( Bennett, S; Borders, CW; Claassen, SL; Mount, C, 2012) |
| " Its long-term use may, however, lead to several adverse effects, with pulmonary toxicity being the most serious." | 1.37 | Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema. ( Bolognese, L; Brandini, R; Caremani, M; Fabiani, I; Grotti, S; Salvadori, C; Tacconi, D, 2011) |
| "Amiodarone was the initial therapy in 26 cases and procainamide in 14 cases." | 1.36 | Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. ( Bar-Cohen, Y; Chang, PM; Moromisato, DY; Silka, MJ, 2010) |
| "The combination of ventricular tachycardia (VT) and severe left ventricular dysfunction presents a serious challenge in management of acute fulminant myocarditis (AFM)." | 1.35 | Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up. ( Acharya, S; Flood, V; Rao, SP; Sathanandam, S; Sharma, JR, 2008) |
| "The amiodarone was omitted in 17 cases because of its side effects." | 1.32 | [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. ( Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G, 2004) |
| "Rats treated with amiodarone had a higher serum creatinine (182%) and a lower glomerular filtration rate (53%), renal plasma flow (68%) and filtration fraction (62%) than controls." | 1.32 | Acute renal toxic effect of amiodarone in rats. ( Arévalo, MA; Barata, JD; Branco, P; Bruges, M; González de Buitrago, JM; Morales, AI; Palma, P; Pérez-Barriocanal, F, 2003) |
| "Amiodarone pulmonary toxicity is a serious adverse effect that can be fatal." | 1.31 | Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. ( Narula, D; Siniakowicz, RM; Steinberg, JS; Suster, B, 2001) |
| "Amiodarone is a commonly used anti-arrhythmic agent, with well-recognized chronic toxicity." | 1.31 | Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? ( Ashrafian, H; Davey, P, 2001) |
| "Congestive heart failure was diagnosed in 6 patients (ejection fraction < 25%) and hypertensive heart failure in 3 patients (ejection infarction > 55%)." | 1.31 | [Control of tachycardia with intravenous amiodarone in acute left heart failure]. ( Arabadzisz, H; Beck, K; Marosi, A; Tomcsányi, J; Zsoldos, A, 2001) |
| "Amiodarone did not increase the incidence of acute organ dysfunction or death after cardiac surgery." | 1.30 | Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery. ( Rady, MY; Ryan, T; Starr, NJ, 1997) |
| "Exposure to the toxic mineral dust silica has been shown to produce an acute inflammatory response in the lungs of both humans and laboratory animals." | 1.29 | Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis. ( Antonini, JM; McCloud, CM; Reasor, MJ, 1994) |
| "Amiodarone is a new and powerful antiarrhythmic agent currently under investigation in North America." | 1.27 | Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease. ( Pollak, PT; Sami, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (14.58) | 18.7374 |
| 1990's | 19 (19.79) | 18.2507 |
| 2000's | 38 (39.58) | 29.6817 |
| 2010's | 22 (22.92) | 24.3611 |
| 2020's | 3 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Benaim, G | 1 |
| Sanders, JM | 1 |
| Garcia-Marchán, Y | 1 |
| Colina, C | 1 |
| Lira, R | 1 |
| Caldera, AR | 1 |
| Payares, G | 1 |
| Sanoja, C | 1 |
| Burgos, JM | 1 |
| Leon-Rossell, A | 1 |
| Concepcion, JL | 1 |
| Schijman, AG | 1 |
| Levin, M | 1 |
| Oldfield, E | 1 |
| Urbina, JA | 1 |
| Mercan Yücel, U | 1 |
| Başbuğan, Y | 1 |
| Uyar, A | 1 |
| Kömüroğlu, AU | 1 |
| Keleş, ÖF | 1 |
| Lakušić, N | 1 |
| Slivnjak, V | 1 |
| Ciglenečki, N | 1 |
| Cerovec, D | 1 |
| Cabrera-Rego, JO | 1 |
| Luzurriaga Navas, JD | 1 |
| Yanes Quintana, AA | 1 |
| El-Khatib, L | 1 |
| Alrayes, H | 1 |
| Sallam, O | 1 |
| Elbanna, A | 1 |
| Yan, S | 1 |
| Yu, J | 1 |
| Xia, Z | 1 |
| Zhu, B | 1 |
| Hu, J | 1 |
| Li, J | 1 |
| Fine, NM | 1 |
| Wang, Y | 1 |
| Khan, A | 1 |
| Vacheron, CH | 1 |
| Allaouchiche, B | 1 |
| Sahud, MA | 1 |
| Caulfield, M | 1 |
| Clarke, N | 1 |
| Koch, R | 1 |
| Bougie, D | 1 |
| Aster, R | 1 |
| Lai, SW | 1 |
| Lin, CL | 1 |
| Liao, KF | 1 |
| Lin, CY | 1 |
| Alonso, A | 1 |
| MacLehose, RF | 1 |
| Lutsey, PL | 1 |
| Konety, S | 1 |
| Chen, LY | 1 |
| Xanthos, T | 2 |
| Psichalakis, N | 1 |
| Russell, D | 1 |
| Papalois, A | 1 |
| Koutsovasilis, A | 1 |
| Athanasopoulos, D | 1 |
| Gkiokas, G | 1 |
| Chalkias, A | 1 |
| Iacovidou, N | 1 |
| Cadiou, G | 1 |
| Varin, R | 1 |
| Levesque, H | 1 |
| Grassi, V | 1 |
| Benichou, J | 1 |
| Tiret, I | 1 |
| Dieu, B | 1 |
| Lecam-Duchez, V | 1 |
| Borg, JY | 1 |
| Muller, JM | 1 |
| Benhamou, Y | 1 |
| Marie, I | 1 |
| Meinertz, T | 1 |
| Willems, S | 1 |
| Lip, GY | 1 |
| Watson, T | 1 |
| Dogan, A | 2 |
| Akcay, S | 1 |
| Karabacak, M | 1 |
| Turker, Y | 1 |
| Ozaydin, M | 2 |
| Erdogan, D | 1 |
| Fabiani, I | 1 |
| Tacconi, D | 1 |
| Grotti, S | 1 |
| Brandini, R | 1 |
| Salvadori, C | 1 |
| Caremani, M | 1 |
| Bolognese, L | 1 |
| Chang, PM | 1 |
| Silka, MJ | 1 |
| Moromisato, DY | 1 |
| Bar-Cohen, Y | 1 |
| Hirschl, MM | 1 |
| Wollmann, C | 1 |
| Globits, S | 1 |
| Conti, A | 1 |
| Del Taglia, B | 1 |
| Mariannini, Y | 1 |
| Pepe, G | 1 |
| Vanni, S | 1 |
| Grifoni, S | 1 |
| Abbate, R | 1 |
| Michelucci, A | 1 |
| Padeletti, L | 1 |
| Gensini, GF | 1 |
| Hsieh, YC | 1 |
| Huang, JL | 1 |
| Chin, CS | 1 |
| Lin, TC | 1 |
| Liao, YC | 1 |
| Ting, CT | 1 |
| Wu, TJ | 1 |
| Camm, AJ | 1 |
| Capucci, A | 1 |
| Hohnloser, SH | 1 |
| Torp-Pedersen, C | 1 |
| Van Gelder, IC | 1 |
| Mangal, B | 1 |
| Beatch, G | 1 |
| Tritakarn, T | 1 |
| Teeratchanan, T | 1 |
| Kumar, S | 1 |
| Bangalore, S | 1 |
| Kumari, R | 1 |
| Grosu, H | 1 |
| Jean, R | 1 |
| von Vital, JM | 1 |
| Karachristos, A | 1 |
| Singhal, A | 1 |
| Thomas, R | 1 |
| Jain, A | 1 |
| Sung, PS | 1 |
| Yoon, SK | 1 |
| Takei, T | 1 |
| Fukushima, H | 1 |
| Hatakeyama, J | 1 |
| Fujisawa, M | 1 |
| Ito, T | 1 |
| Karnatovskaia, LV | 1 |
| Festic, E | 1 |
| Gajic, O | 1 |
| Carter, RE | 1 |
| Lee, AS | 1 |
| Chevalier, P | 1 |
| Timour, Q | 1 |
| Morel, E | 1 |
| Bui-Xuan, B | 1 |
| Borders, CW | 1 |
| Bennett, S | 1 |
| Mount, C | 1 |
| Claassen, SL | 1 |
| Gregory, SA | 1 |
| Webster, JB | 1 |
| Chapman, GD | 1 |
| Agozzino, F | 1 |
| Picca, M | 1 |
| Pelosi, G | 1 |
| Morales, AI | 1 |
| Barata, JD | 1 |
| Bruges, M | 1 |
| Arévalo, MA | 1 |
| González de Buitrago, JM | 1 |
| Palma, P | 1 |
| Branco, P | 1 |
| Pérez-Barriocanal, F | 1 |
| Kohno, M | 1 |
| Card, JW | 1 |
| Racz, WJ | 1 |
| Brien, JF | 1 |
| Margolin, SB | 1 |
| Massey, TE | 1 |
| Olsson, R | 1 |
| Barbisan, JN | 1 |
| Fuchs, FD | 1 |
| D'Agord Schaan, B | 1 |
| Tereshchenko, SN | 1 |
| Bulanova, NA | 1 |
| Kositsyna, IV | 1 |
| Morozova, MN | 1 |
| Uteshev, IuA | 1 |
| Márk, L | 1 |
| Erdej, F | 1 |
| Dani, G | 1 |
| Borbély, M | 1 |
| Sziklai, G | 1 |
| Nagy, E | 1 |
| Hajdara, I | 1 |
| Katona, A | 1 |
| Khalil, SI | 1 |
| Kamal, A | 1 |
| Ahmad, S | 1 |
| Famularo, G | 1 |
| Minisola, G | 1 |
| Nicotra, GC | 1 |
| De Simone, C | 1 |
| Bridgman, PG | 1 |
| Kafkas, NV | 1 |
| Patsilinakos, SP | 1 |
| Mertzanos, GA | 1 |
| Papageorgiou, KI | 1 |
| Chaveles, JI | 1 |
| Dagadaki, OK | 1 |
| Kelesidis, KM | 1 |
| Kukla, P | 1 |
| Bryniarski, L | 1 |
| Dragan, J | 1 |
| Słowiak-Lewińska, T | 1 |
| Czamara, M | 1 |
| Bromblik, A | 1 |
| Szczuka, K | 1 |
| O'Donnell, MJ | 1 |
| Valens, N | 1 |
| Lansberg, MG | 1 |
| Wijman, CA | 1 |
| Chen, YY | 1 |
| Chen, CY | 1 |
| Leung, KK | 1 |
| Varol, E | 1 |
| Aslan, SM | 1 |
| Altínbas, A | 1 |
| Carrió, ML | 1 |
| Fortià, C | 1 |
| Javierre, C | 1 |
| Rodríguez, D | 1 |
| Farrero, E | 1 |
| Ricart, A | 1 |
| Castells, E | 1 |
| Ventura, JL | 1 |
| Prapa, V | 1 |
| Papadimitriou, D | 1 |
| Papadimitriou, L | 1 |
| Sharma, JR | 1 |
| Sathanandam, S | 1 |
| Rao, SP | 1 |
| Acharya, S | 1 |
| Flood, V | 1 |
| Argyriou, M | 1 |
| Hountis, P | 1 |
| Antonopoulos, N | 1 |
| Mathioudaki, M | 1 |
| Blank, W | 1 |
| Braun, B | 1 |
| Pollak, PT | 1 |
| Sami, M | 1 |
| Oreto, G | 1 |
| Lapresa, V | 1 |
| Melluso, C | 1 |
| Manganaro, A | 1 |
| Arrigo, F | 1 |
| Nademanee, K | 1 |
| Singh, BN | 1 |
| Hendrickson, J | 1 |
| Intarachot, V | 1 |
| Lopez, B | 1 |
| Feld, G | 1 |
| Cannom, DS | 1 |
| Weiss, JL | 1 |
| Marcus, FI | 1 |
| Fontaine, GH | 1 |
| Frank, R | 1 |
| Grosgogeat, Y | 1 |
| Tosetti, C | 1 |
| Ongari, M | 1 |
| Evangelisti, A | 1 |
| Lolli, R | 1 |
| Napoli, A | 1 |
| César, LA | 1 |
| Serrano, CV | 1 |
| Pamplona, D | 1 |
| D'Avila, AL | 1 |
| Ferreira, JF | 1 |
| Amato, RV | 1 |
| Pfeferman, E | 1 |
| Scanavacca, M | 1 |
| Sosa, EA | 1 |
| Bellotti, G | 1 |
| Blake, TL | 1 |
| Reasor, MJ | 2 |
| Antonini, JM | 1 |
| McCloud, CM | 1 |
| Rhodes, A | 1 |
| Eastwood, JB | 1 |
| Smith, SA | 1 |
| Kumar, A | 1 |
| Oltrona, L | 1 |
| Broccolino, M | 1 |
| Merlini, PA | 1 |
| Spinola, A | 1 |
| Pezzano, A | 1 |
| Mannucci, PM | 1 |
| Goldstein, I | 1 |
| Topilsky, M | 1 |
| Segev, D | 1 |
| Isakov, A | 1 |
| Heller, I | 1 |
| Rady, MY | 1 |
| Ryan, T | 1 |
| Starr, NJ | 1 |
| Daniels, CJ | 1 |
| Schutte, DA | 1 |
| Hammond, S | 1 |
| Franklin, WH | 1 |
| Bosch, X | 1 |
| Bernadich, O | 1 |
| Tagliamonte, E | 1 |
| Cice, G | 1 |
| Ducceschi, V | 1 |
| Mayer, MS | 1 |
| Iacono, A | 1 |
| Votey, SR | 1 |
| Herbert, ME | 1 |
| López-Gómez, D | 1 |
| Nicolás, J | 1 |
| Frigola, JM | 1 |
| Manito, N | 1 |
| Esplugas, E | 1 |
| Iskander, S | 1 |
| Raible, DG | 1 |
| Brozena, SC | 1 |
| Gaitanaru, DM | 1 |
| Ayala, G | 1 |
| Iskandrian, AE | 1 |
| Carrión Valero, F | 1 |
| Marín Pardo, J | 1 |
| Khand, AU | 1 |
| Rankin, AC | 1 |
| Kaye, GC | 1 |
| Cleland, JG | 1 |
| Claxton, S | 1 |
| Sinha, SN | 1 |
| Donovan, S | 1 |
| Greenaway, TM | 1 |
| Hoffman, L | 1 |
| Loughhead, M | 1 |
| Burgess, JR | 1 |
| Bianconi, L | 1 |
| Castro, A | 1 |
| Dinelli, M | 1 |
| Alboni, P | 1 |
| Pappalardo, A | 1 |
| Richiardi, E | 1 |
| Santini, M | 1 |
| Kristin, N | 1 |
| Ulbig, M | 1 |
| Siniakowicz, RM | 1 |
| Narula, D | 1 |
| Suster, B | 1 |
| Steinberg, JS | 1 |
| Ashrafian, H | 1 |
| Davey, P | 1 |
| Kaushik, S | 1 |
| Hussain, A | 1 |
| Clarke, P | 1 |
| Lazar, HL | 1 |
| Tomcsányi, J | 1 |
| Arabadzisz, H | 1 |
| Zsoldos, A | 1 |
| Marosi, A | 1 |
| Beck, K | 1 |
| Kharabsheh, S | 1 |
| Abendroth, CS | 1 |
| Kozak, M | 1 |
| Kochiadakis, GE | 1 |
| Skalidis, EI | 1 |
| Kalebubas, MD | 1 |
| Igoumenidis, NE | 1 |
| Chrysostomakis, SI | 1 |
| Kanoupakis, EM | 1 |
| Simantirakis, EN | 1 |
| Vardas, PE | 1 |
| Lardinois, D | 1 |
| Handschin, A | 1 |
| Weder, W | 1 |
| Frabetti, L | 1 |
| Perticucci, R | 1 |
| De Garaté, S | 1 |
| Bracchetti, D | 1 |
| Magnani, B | 1 |
| Fornaciari, G | 1 |
| Monducci, I | 1 |
| Barone, A | 1 |
| Bassi, C | 1 |
| Beltrami, M | 1 |
| Tomasi, C | 1 |
| Lossos, IS | 1 |
| Matzner, Y | 1 |
| Quadrado, C | 1 |
| Soares, Ade O | 1 |
| de Castro, JJ | 1 |
| Mota, E | 1 |
| Greco, R | 1 |
| D'Alterio, D | 1 |
| Schiattarella, M | 1 |
| Musto, B | 1 |
| Wolff, S | 1 |
| Boccia, AS | 1 |
| Mininni, N | 1 |
| Clouston, PD | 1 |
| Donnelly, PE | 1 |
| Goddard, CJ | 1 |
| Whorwell, PJ | 1 |
| Stevenson, RN | 1 |
| Nayani, TH | 1 |
| Davies, JR | 1 |
| Rigas, B | 1 |
| Pye, M | 1 |
| Northcote, RJ | 1 |
| Cobbe, SM | 1 |
| Schmidt, A | 1 |
| König, W | 1 |
| Binner, L | 1 |
| Mayer, U | 1 |
| Stauch, M | 1 |
| Kheĭnonen, IM | 1 |
| Semikhatova, OB | 1 |
| Aretinskiĭ, VV | 1 |
| de Korwin, JD | 1 |
| Gagey, S | 1 |
| Paille, F | 1 |
| Zannad, F | 1 |
| Schmitt, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Trial Testing Amiodarone in Chagas Cardiomyopathy (ATTACH)[NCT03193749] | Phase 3 | 200 participants (Anticipated) | Interventional | 2017-06-12 | Recruiting | ||
| Multicenter Study for the Prevention of Post-Operative Cardiac Arrhythmias[NCT04234906] | Phase 4 | 870 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | ||
| A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection Versus Amiodarone in Subjects With Recent Onset Atrial Fibrillation[NCT00668759] | Phase 3 | 254 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation[NCT01447862] | Phase 4 | 101 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients[NCT04748991] | Phase 3 | 50 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for amiodarone and Acute Disease
| Article | Year |
|---|---|
[Treatment of atrial fibrillation in every days practice].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chronic D | 2008 |
Atrial fibrillation (acute onset).
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol | 2008 |
[Pharmacological treatment of heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensi | 2003 |
[Chronic heart failure and atrial fibrilation: aspects of management].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmi | 2003 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
[Acute hepatotoxicity from amiodarone].
Topics: Acute Disease; Aged; Amiodarone; Chemical and Drug Induced Liver Injury; Humans; Liver; Male; Necros | 1995 |
[Acute hepatitis following amiodarone administration].
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Electrocardiography; Humans; Male | 1997 |
[The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced L | 1999 |
[Pulmonary toxicity caused by drugs].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory | 1999 |
Systematic review of the management of atrial fibrillation in patients with heart failure.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Chronic Dise | 2000 |
Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Middle Aged; Tasmania; Thyroi | 2000 |
10 trials available for amiodarone and Acute Disease
| Article | Year |
|---|---|
Management of patients with acute atrial fibrillation in the ED.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; | 2010 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow- | 2011 |
Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk.
Topics: Acute Disease; Acute Lung Injury; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; M | 2012 |
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Respon | 2007 |
Is short-term amiodarone use post cardiac surgery a cause of acute respiratory failure?
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Gas Analysis; Ca | 2007 |
Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Digoxi | 2007 |
[Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?].
Topics: Acute Disease; Adult; Aged; Amiodarone; Atrial Fibrillation; Emergencies; Female; Humans; Male; Midd | 1994 |
Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atria | 2000 |
[Clinical evaluation of the use of i.v. amiodarone in the treatment of arrhythmias].
Topics: Acute Disease; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Tria | 1979 |
Intravenous amiodarone in acute anterior myocardial infarction: a controlled study.
Topics: Acute Disease; Adult; Aged; Amiodarone; Female; Humans; Injections, Intravenous; Male; Middle Aged; | 1989 |
75 other studies available for amiodarone and Acute Disease
| Article | Year |
|---|---|
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
Topics: Acute Disease; Amiodarone; Animals; Calcium; Chagas Disease; Chlorocebus aethiops; Crystallography, | 2006 |
Use of an antiarrhythmic drug against acute selenium toxicity.
Topics: Acute Disease; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Vessels; Myo | 2020 |
TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Ele | 2019 |
[Acute amiodarone pulmonary toxicity with low impregnation dose: case report].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, | 2020 |
Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Dru | 2020 |
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzaze | 2018 |
Acute Decompensated Heart Failure After Initiation of Amiodarone in a Patient With Anderson-Fabry Disease.
Topics: Acute Disease; Administration, Oral; Amiodarone; Biopsy; Cytochrome P-450 CYP1A2 Inhibitors; Echocar | 2019 |
Assessing severe alteration of tissue perfusion during atrial fibrillation using esophageal photoplethysmography.
Topics: Acute Disease; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pre | 2019 |
Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Autoantibodies; Female; Humans; Immunoglobu | 2013 |
Amiodarone use and risk of acute pancreatitis: A population-based case-control study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Card | 2015 |
Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; | 2015 |
Intralipid™ administration attenuates the hypotensive effects of acute intravenous amiodarone overdose in a swine model.
Topics: Acute Disease; Amiodarone; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationsh | 2016 |
Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Blood Coagulation Disorde | 2008 |
The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Elect | 2009 |
Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillatio | 2011 |
Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Hear | 2010 |
A 2-year survey of treatment of acute atrial fibrillation in an ED.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2011 |
Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantab | 2011 |
Acute rhabdomyolysis and cardiac arrest following succinylcholine in a patient with Parry-Romberg syndrome.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Calcium Gluconate; Cardiopulmonary Re | 2011 |
Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure.
Topics: Acute Disease; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Femal | 2012 |
Acute amiodarone hepatotoxicity after liver transplantation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Hepatocellular; C | 2011 |
Amiodarone hepatotoxicity.
Topics: Acute Disease; Aged; Amiodarone; Chemical and Drug Induced Liver Injury; Humans; Hypertension; Male; | 2012 |
Acute amiodarone poisoning occurring twice in the same subject.
Topics: Acute Disease; Aged; Amiodarone; Antidotes; Charcoal; Humans; Male; Phenobarbital; Suicide, Attempte | 2011 |
Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
Topics: Acute Disease; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Occlusion | 2012 |
A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: a case report.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Fatal Outcome; Hemorrh | 2012 |
Acute hepatitis induced by parenteral amiodarone.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Dos | 2002 |
Acute hepatitis complicating intravenous amiodarone treatment.
Topics: Acute Disease; Acute Kidney Injury; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; C | 2002 |
Acute renal toxic effect of amiodarone in rats.
Topics: Acute Disease; Amiodarone; Animals; Anti-Arrhythmia Agents; Creatinine; Injections, Intraperitoneal; | 2003 |
Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Topics: Acute Disease; Amiodarone; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; | 2003 |
Acute hepatitis after parenteral amiodarone.
Topics: Acute Disease; Acute Kidney Injury; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemica | 2003 |
Prevalence of thyroid dysfunction in patients with acute atrial fibrillation attended at a cardiology emergency room.
Topics: Acute Disease; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cross-Sectional Studies; Female; Hum | 2003 |
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrill | 2004 |
Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Coron | 2004 |
Acute pancreatitis caused by amiodarone.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Dose- | 2004 |
Late presentation of a cardiomyopathy provoked by sudden emotional stress.
Topics: Acute Disease; Adult; Amiodarone; Cardiomyopathies; Contraindications; Female; Humans; Stress, Psych | 2006 |
[Polymorphic ventricular tachycardia in acute myocardial infarction without ST elevation in a patient with thrombocytopenia].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Angiography; Electrocardiography; | 2006 |
Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bra | 2006 |
Acute pancreatitis and amiodarone: a case report.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Pancreatitis; Propafenone; | 2007 |
Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Dopamine; Drug Therapy, | 2007 |
Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Drug Th | 2008 |
Acute fatal post-CABG low dose amiodarone lung toxicity.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass | 2007 |
[Sonography of the thyroid--part 2: thyroid inflammation, impairmant of thyroid function and interventions].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Female; Humans; Hyperthyroidism; | 2008 |
Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease.
Topics: Acute Disease; Aged; Amiodarone; Benzofurans; Humans; Hyperglycemia; Lung; Male; Necrosis; Pneumonia | 1984 |
[Acute amiodarone poisoning. Description of a case].
Topics: Acute Disease; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Humans; Suicide, Attempte | 1980 |
Amiodarone in refractory life-threatening ventricular arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Fema | 1983 |
Acute pulmonary inflammation in hamsters following intratracheal administration of amiodarone.
Topics: Acute Disease; Amiodarone; Animals; Bronchoalveolar Lavage Fluid; Cricetinae; Intubation, Intratrach | 1995 |
Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis.
Topics: Acute Disease; Amiodarone; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Lipidoses; | 1994 |
Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?
Topics: Acute Disease; Acute Kidney Injury; Administration, Oral; Aged; Amiodarone; Chemical and Drug Induce | 1993 |
Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Critic | 1996 |
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Antithrombin III; Atrial Fibrillation; Biomarkers | 1997 |
Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cough; Dyspnea; Fever; | 1997 |
Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Blood Chemical Analysis; Cardiac Surgical Procedu | 1997 |
Acute pulmonary toxicity in an infant from intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Bronchoalveolar Lavage Fluid; Dobutamine; Humans; Infant; Infant, Newborn | 1997 |
Acute pancreatitis during treatment with amiodarone.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Middle Aged; Pancreatitis | 1997 |
Intravenous amiodarone for treating acute life threatening arrhythmias.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Humans; Injections, Intravenous; Tachycardia; Ven | 1998 |
Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Hemorrhage; Humans; Hypoxia; Lung Disease | 1999 |
[Acute papilledema. A 69-year-old patient with acute bilateral papilledema].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Male; Papilledem | 2001 |
Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Amiodarone; Case-Control Studies; C | 2001 |
Is amiodarone an underrecognized cause of acute respiratory failure in the ICU?
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Heart; Humans; Inten | 2001 |
Acute pulmonary toxicity after low-dose amiodarone therapy.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases; Male | 2001 |
[Control of tachycardia with intravenous amiodarone in acute left heart failure].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Infusions, I | 2001 |
Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Administration Schedule; Fatal Outcome | 2002 |
Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
Topics: Acute Disease; Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Fun | 2002 |
Acute amiodarone-induced pulmonary toxicity after lung operation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Diseases; Pneum | 2002 |
Amiodarone-induced acute hepatitis: case report.
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Female; Humans; Middle Aged | 1992 |
Aplastic anemia associated with amiodarone therapy.
Topics: Acute Disease; Aged; Amiodarone; Anemia, Aplastic; Humans; Male; Pre-Excitation Syndromes | 1992 |
[The effectiveness of amiodarone seems to depend highly on the pathology underlying the arrhythmia].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Heart Disea | 1990 |
Acute necrotising myopathy associated with amiodarone therapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Humans; Hypothyroidism; Male; Muscles; Muscular | 1989 |
Amiodarone overdose and its management.
Topics: Acute Disease; Adolescent; Amiodarone; Cholestyramine Resin; Female; Gastric Lavage; Humans | 1989 |
Acute hepatic dysfunction following parenteral amiodarone administration.
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Humans; Infusions, Intravenous; M | 1989 |
The evolving spectrum of amiodarone hepatotoxicity.
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Humans; Injections, Intravenous | 1989 |
Acute hepatitis after parenteral amiodarone administration.
Topics: Acute Disease; Aged; Amiodarone; Chemical and Drug Induced Liver Injury; Female; Humans; Infusions, | 1988 |
Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
Topics: Acute Disease; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Infu | 1988 |
[Effect of cordarone on the size of the lesion in patients with acute myocardial infarction].
Topics: Acute Disease; Adult; Aged; Amiodarone; Blood Pressure; Creatine Kinase; Electrocardiography; Humans | 1987 |
[Acute hepatitis attributed to amiodarone].
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Humans; Male; Middle Aged | 1986 |